Walmsley Emma N.'s Insider Trades & SAST Disclosures
Walmsley Emma N.'s most recent trade in GSK Plc - ADR was a trade of 9 Ords 0.31p done at an average price of $13.6 . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Walmsley Emma N..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.56 per share. | 12 May 2025 | 9 | 2,419,573 (0%) | 0% | 13.6 | 122 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 12 May 2025 | 9 | 2,419,582 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 06 May 2025 | 11,643 | 2,425,037 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 06 May 2025 | 5,473 | 2,419,564 (0%) | 0% | 14.5 | 79,302 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 12.75 per share. | 16 Apr 2025 | 1,924 | 2,413,394 (0%) | 0% | 12.8 | 24,531 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 12.75 per share. | 16 Apr 2025 | 1,702 | 2,411,470 (0%) | 0% | 12.8 | 21,701 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 12.75 per share. | 16 Apr 2025 | 1,304 | 2,409,768 (0%) | 0% | 12.8 | 16,626 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.07 per share. | 10 Apr 2025 | 4,560 | 2,408,464 (0%) | 0% | 13.1 | 59,585 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.11 per share. | 10 Apr 2025 | 35 | 2,403,904 (0%) | 0% | 13.1 | 459 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 12.60 per share. | 10 Apr 2025 | 10 | 2,403,859 (0%) | 0% | 12.6 | 126 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Apr 2025 | 10 | 2,403,869 (0%) | 0% | 0 | Ords 0.31p | ||
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 1 | 569 | - | - | Restricted Stock Units | |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 11 Mar 2025 | 8 | 2,403,849 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.50 per share. | 11 Mar 2025 | 8 | 2,403,841 (0%) | 0% | 15.5 | 124 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 21 Feb 2025 | 123,700 | 2,403,833 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 18 Feb 2025 | 420,177 | 2,527,533 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 17 Feb 2025 | 81,703 | 632,434 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.18 per share. | 17 Feb 2025 | 38,459 | 593,975 (0%) | 0% | 14.2 | 545,418 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 11 Feb 2025 | 9 | 550,731 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.56 per share. | 11 Feb 2025 | 9 | 550,722 (0%) | 0% | 14.6 | 131 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Feb 2025 | 256,706 | 671,366 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.53 per share. | 10 Feb 2025 | 120,653 | 550,713 (0%) | 0% | 14.5 | 1,753,317 | Ords 0.31p |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 150 | 568 | - | - | Restricted Stock Units | |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.49 per share. | 14 Jan 2025 | 8,001 | 414,660 (0%) | 0% | 13.5 | 107,973 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.50 per share. | 14 Jan 2025 | 1,686 | 406,659 (0%) | 0% | 13.5 | 22,753 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.50 per share. | 14 Jan 2025 | 1,492 | 404,973 (0%) | 0% | 13.5 | 20,135 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.50 per share. | 14 Jan 2025 | 898 | 403,481 (0%) | 0% | 13.5 | 12,119 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Jan 2025 | 9 | 402,583 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.44 per share. | 10 Jan 2025 | 9 | 402,574 (0%) | 0% | 13.4 | 121 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.56 per share. | 09 Jan 2025 | 2,113 | 402,535 (0%) | 0% | 13.6 | 28,647 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.60 per share. | 09 Jan 2025 | 30 | 402,565 (0%) | 0% | 13.6 | 408 | Ords 0.31p |
| GSK Plc - ADR | Walmsley N. Emma | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.89 per share. | 10 Dec 2024 | 9 | 400,413 (0%) | 0% | 13.9 | 125 | Ords 0.31p |
| GSK Plc - ADR | Walmsley N. Emma | Executive Director,Chief Executive Officer | 10 Dec 2024 | 9 | 400,422 (0%) | 0% | 0 | Ords 0.31p | ||
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 131 | 417 | - | - | Restricted Stock Units | |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 11 Nov 2024 | 9 | 400,404 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 11 Nov 2024 | 9 | 400,395 (0%) | 0% | 14 | 126 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Oct 2024 | 7,104 | 398,479 (0%) | 0% | 15.0 | 106,915 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 14.87 per share. | 15 Oct 2024 | 1,907 | 400,386 (0%) | 0% | 14.9 | 28,366 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Oct 2024 | 1,497 | 391,375 (0%) | 0% | 15.1 | 22,530 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Oct 2024 | 1,324 | 389,878 (0%) | 0% | 15.0 | 19,926 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Oct 2024 | 797 | 388,554 (0%) | 0% | 15.1 | 11,995 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.27 per share. | 10 Oct 2024 | 26 | 387,757 (0%) | 0% | 15.3 | 397 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.50 per share. | 09 Oct 2024 | 8 | 387,723 (0%) | 0% | 14.5 | 116 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Oct 2024 | 8 | 387,731 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Sep 2024 | 8 | 387,715 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.75 per share. | 10 Sep 2024 | 8 | 387,707 (0%) | 0% | 16.8 | 134 | Ords 0.31p |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 146 | 285 | - | - | Restricted Stock Units | |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Aug 2024 | 8 | 387,699 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.50 per share. | 09 Aug 2024 | 8 | 387,691 (0%) | 0% | 15.5 | 124 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 14.93 per share. | 16 Jul 2024 | 1,881 | 387,683 (0%) | 0% | 14.9 | 28,087 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Jul 2024 | 7,033 | 385,802 (0%) | 0% | 15.1 | 105,847 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Jul 2024 | 1,482 | 378,769 (0%) | 0% | 15.0 | 22,304 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Jul 2024 | 1,311 | 377,287 (0%) | 0% | 15.1 | 19,731 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.05 per share. | 15 Jul 2024 | 789 | 375,976 (0%) | 0% | 15.0 | 11,874 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.12 per share. | 11 Jul 2024 | 26 | 375,187 (0%) | 0% | 15.1 | 393 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Jul 2024 | 8 | 375,161 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.12 per share. | 09 Jul 2024 | 8 | 375,153 (0%) | 0% | 15.1 | 121 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 20 Jun 2024 | 371,100 | 375,145 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.25 per share. | 11 Jun 2024 | 8 | 746,237 (0%) | 0% | 16.3 | 130 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 11 Jun 2024 | 8 | 746,245 (0%) | 0% | 0 | Ords 0.31p | ||
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 138 | 138 | - | - | Restricted Stock Units | |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 May 2024 | 7 | 746,229 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 May 2024 | 7 | 746,222 (0%) | 0% | 18 | 126 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.29 per share. | 16 Apr 2024 | 6,864 | 744,374 (0%) | 0% | 16.3 | 111,815 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.11 per share. | 16 Apr 2024 | 1,841 | 746,215 (0%) | 0% | 16.1 | 29,664 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.29 per share. | 16 Apr 2024 | 1,446 | 737,510 (0%) | 0% | 16.3 | 23,555 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.29 per share. | 16 Apr 2024 | 1,279 | 736,064 (0%) | 0% | 16.3 | 20,835 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.29 per share. | 16 Apr 2024 | 770 | 734,785 (0%) | 0% | 16.3 | 12,543 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 16.29 per share. | 11 Apr 2024 | 24 | 734,015 (0%) | 0% | 16.3 | 391 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Apr 2024 | 8 | 733,991 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.12 per share. | 10 Apr 2024 | 8 | 733,983 (0%) | 0% | 16.1 | 129 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 11 Mar 2024 | 7 | 733,975 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.71 per share. | 11 Mar 2024 | 7 | 733,968 (0%) | 0% | 16.7 | 117 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 16 Feb 2024 | 297,429 | 8,998,985 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Walmsley Emma N. | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.58 per share. | 16 Feb 2024 | 139,792 | 8,859,193 (0%) | 0% | 16.6 | 2,317,709 | Ords 0.31p |
| GSK Plc - ADR | Emma Walmsley N. | Executive Director,Chief Executive Officer | 12 Feb 2024 | 52,435 | 8,726,238 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 12 Feb 2024 | 24,682 | 8,701,556 (0%) | 0% | 16.5 | 407,697 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Feb 2024 | 441,309 | 8,232,494 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma Walmsley N. | Executive Director,Chief Executive Officer | 09 Feb 2024 | 441,309 | 8,673,803 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Feb 2024 | 8 | 7,791,185 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK Plc - ADR | Walmsley Emma N. | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.62 per share. | 09 Feb 2024 | 8 | 7,791,177 (0%) | 0% | 16.6 | 133 | Ords 0.31p |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 148 | 9,958 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 401.20 per share. | 31 Jan 2024 | 44 | 9,913 (0%) | 0% | 401.2 | 17,653 | Common Stock |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.56 per share. | 15 Jan 2024 | 4,947 | 7,643,898 (0%) | 0% | 15.6 | 76,995 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.56 per share. | 15 Jan 2024 | 1,161 | 7,637,785 (0%) | 0% | 15.6 | 18,070 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.56 per share. | 15 Jan 2024 | 699 | 7,638,484 (0%) | 0% | 15.6 | 10,879 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.56 per share. | 15 Jan 2024 | 467 | 7,638,951 (0%) | 0% | 15.6 | 7,268 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 15.64 per share. | 11 Jan 2024 | 22 | 7,636,624 (0%) | 0% | 15.6 | 344 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 15.71 per share. | 10 Jan 2024 | 7 | 7,636,595 (0%) | 0% | 15.7 | 110 | Ords 0.31p |
| GSK Plc - ADR | Emma N. Walmsley | Executive Director,Chief Executive Officer | 10 Jan 2024 | 7 | 7,636,602 (0%) | 0% | 0 | Ords 0.31p | ||
| Microsoft Corporation | Emma Walmsley N. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 159 | 9,857 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 374.30 per share. | 06 Dec 2023 | 47 | 9,810 (0%) | 0% | 374.3 | 17,592 | Common Stock |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 237 | 9,525 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.15 per share. | 31 Jan 2023 | 71 | 9,453 (0%) | 0% | 248.2 | 17,619 | Common Stock |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 233 | 9,357 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 255.81 per share. | 12 Dec 2022 | 69 | 9,288 (0%) | 0% | 255.8 | 17,651 | Common Stock |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2022 | 223 | 9,191 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 266.56 per share. | 30 Aug 2022 | 66 | 9,124 (0%) | 0% | 266.6 | 17,593 | Common Stock |
| Microsoft Corporation | Emma N. Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 215 | 9,033 (0%) | 0% | 0 | Common Stock | |
| Microsoft Corporation | Emma N. Walmsley | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.38 per share. | 31 May 2022 | 64 | 8,968 (0%) | 0% | 275.4 | 17,624 | Common Stock |
| Microsoft Corporation | Emma N. Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 295.48 per share. | 28 Jan 2022 | 1,700 | 7,086 (0%) | 0% | 295.5 | 502,317 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges